{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:07:23Z","timestamp":1790813243635,"version":"4.1.0"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Despite advances in antiretroviral therapy (ART), human immunodeficiency virus type 1 (HIV-1) remains a global health challenge, with approximately 39 million people infected worldwide, persistent viral reservoirs, and delayed immune reconstitution. Exosomes, which are extracellular vesicles (30\u2013150 nm) that play a key role in intercellular communication, have a dual role in HIV-1 pathogenesis and therapy. Regarding pathogenesis, this review elucidates how HIV-1 exploits the exosome pathway\u2014hijacking the Endosomal Sorting Complex Required for Transport(ESCRT)machinery for viral budding and selectively packaging viral components, such as the accessory protein Nef, to enhance infectivity, promote immune evasion, and establish latent reservoirs. Conversely, host cells utilize exosomes to mount antiviral defense by packaging and transmitting restriction factors, such as APOBEC3G, to recipient cells. Furthermore, exosomal cargo serves as promising biomarkers for disease monitoring, and exosomes themselves are emerging as versatile therapeutic nanocarriers. We highlight that plant-derived exosomes offer unique advantages, including low immunogenicity and high scalability, for delivering next-generation antiviral agents or gene editing tools. In summary, understanding the multifaceted roles of exosomes provides crucial mechanistic insights into HIV-1 pathogenesis and unveils innovative strategies toward a functional cure.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1634726","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:17:24Z","timestamp":1763619444000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Exosomes at the crossroads of HIV-1 pathogenesis and therapeutics"],"prefix":"10.3389","volume":"16","author":[{"given":"Pengpeng","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"B1","unstructured":"HIV and AIDS\n          \n          \n          \n          2024"},{"key":"B2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/1874613601610010034","article-title":"HIV infection and AIDS in sub-saharan africa: current status, challenges and opportunities","volume":"10","author":"Kharsany","year":"2016","journal-title":"Open AIDS J"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1079990","article-title":"Key populations and Sub-Saharan Africa's HIV response","volume":"11","author":"Moyo","year":"2023","journal-title":"Front Public Health"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/16549716.2025.2474787","article-title":"Exploring socio-economic dimensions in HIV research: a comprehensive bibliometric analysis (1992-2024)","volume":"18","author":"Yermukhanova","year":"2025","journal-title":"Glob Health Action"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(23)00136-4","article-title":"Efficacy, safety, and tolerability of switching to long-acting cabotegravir plus rilpivirine versus continuing fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV, 12-month results (SOLAR): a randomised, open-label, phase 3b, non-inferiority trial","volume":"10","author":"Ramgopal","year":"2023","journal-title":"Lancet HIV"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30099-0","article-title":"Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials","volume":"7","author":"Orkin","year":"2020","journal-title":"Lancet HIV"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052621","article-title":"HIV reservoirs and treatment strategies toward curing HIV infection","volume":"25","author":"Matsuda","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B8","unstructured":"Fact sheet: HIV drug resistance"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2017.00074","article-title":"Off-target effects of drugs that disrupt human mitochondrial DNA maintenance","volume":"4","author":"Young","year":"2017","journal-title":"Front Mol Biosci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/JLB.4MR1019-189R","article-title":"Incomplete immune reconstitution in HIV\/AIDS patients on antiretroviral therapy: Challenges of immunological non-responders","volume":"107","author":"Yang","year":"2020","journal-title":"J Leukoc Biol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1527936","article-title":"Nutritional risk and HbA1c as critical risk factors and predictors of opportunistic infections in HIV-DM comorbid patients: a retrospective cross-sectional study","volume":"15","author":"Zhu","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B12","article-title":"HIV and AIDS","volume-title":"StatPearls","author":"Swinkels","year":"2025"},{"key":"B13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12981-025-00734-8","article-title":"Clinical trials of broadly neutralizing monoclonal antibodies in people living with HIV - a review","volume":"22","author":"Mahomed","year":"2025","journal-title":"AIDS Res Ther"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1038\/s41467-025-58371-8","article-title":"Multilayered HIV-1 resistance in HSPCs through CCR5 Knockout and B cell secretion of HIV-inhibiting antibodies","volume":"16","author":"Feist","year":"2025","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/cells8070727","article-title":"Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis","volume":"8","author":"Doyle","year":"2019","journal-title":"Cells"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e12352","DOI":"10.1002\/jev2.12352","article-title":"Differential proteomics argues against a general role for CD9, CD81 or CD63 in the sorting of proteins into extracellular vesicles","volume":"12","author":"Fan","year":"2023","journal-title":"J Extracell Vesicles"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1249133","article-title":"Exosomes multifunctional roles in HIV-1: insight into the immune regulation, vaccine development and current progress in delivery system","volume":"14","author":"Habib","year":"2023","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.1038\/s41467-021-25839-2","article-title":"Exosome-mediated stable epigenetic repression of HIV-1","volume":"12","author":"Shrivastava","year":"2021","journal-title":"Nat Commun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.7150\/thno.52570","article-title":"Engineering exosomes for targeted drug delivery","volume":"11","author":"Liang","year":"2021","journal-title":"Theranostics"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1042\/BST0370181","article-title":"The ESCRT pathway and HIV-1 budding","volume":"37","author":"Usami","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(03)00714-1","article-title":"The protein network of HIV budding","volume":"114","author":"von Schwedler","year":"2003","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2006.03.013","article-title":"Structural basis for budding by the ESCRT-III factor CHMP3","volume":"10","author":"Muzio\u0142","year":"2006","journal-title":"Dev Cell"},{"key":"B23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.semcdb.2017.08.022","article-title":"Biogenesis and function of ESCRT-dependent extracellular vesicles","volume":"74","author":"Juan","year":"2018","journal-title":"Semin Cell Dev Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01712-14","article-title":"Exosomes from human immunodeficiency virus type 1 (HIV-1)-infected cells license quiescent CD4+ T lymphocytes to replicate HIV-1 through a Nef- and ADAM17-dependent mechanism","volume":"88","author":"Arenaccio","year":"2014","journal-title":"J Virol"},{"key":"B25","first-page":"S2","article-title":"HIV-1 Nef protein is\u00a0secreted into vesicles that can fuse with target cells and virions","volume":"18","author":"Campbell","year":"2008","journal-title":"Ethn Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000159","article-title":"Exosomes from breast milk inhibit HIV-1 infection of dendritic cells and subsequent viral transfer to CD4+ T cells","volume":"28","author":"N\u00e4slund","year":"2014","journal-title":"AIDS"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01658-08","article-title":"Exosomes packaging APOBEC3G confer human immunodeficiency virus resistance to recipient cells","volume":"83","author":"Khatua","year":"2009","journal-title":"J Virol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05779-1","article-title":"The structural basis for HIV-1 Vif antagonism of human APOBEC3G","volume":"615","author":"Li","year":"2023","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.03293-19","article-title":"Mycobacterium tuberculosis Reactivates HIV-1 via Exosome-Mediated Resetting of Cellular Redox\u00a0Potential and Bioenergetics","volume":"11","author":"Tyagi","year":"2020","journal-title":"mBio"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-018-3737-6","article-title":"Tetraspanin blockage reduces exosome-mediated HIV-1 entry","volume":"163","author":"Sims","year":"2018","journal-title":"Arch Virol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13175","article-title":"Early events in hepatitis B virus infection: From the cell surface to the nucleus","volume":"31","author":"Hayes","year":"2016","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e1005123","DOI":"10.1371\/journal.ppat.1005123","article-title":"The dual role of an ESCRT-0 component HGS in HBV transcription and naked capsid secretion","volume":"11","author":"Chou","year":"2015","journal-title":"PloS Pathog"},{"key":"B33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-1-0716-1190-6_2","article-title":"Regulation of the small GTPase Ras and its relevance to human disease","volume":"2262","author":"Kulhanek","year":"2021","journal-title":"Methods Mol Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.017285-0","article-title":"Vps4 and the ESCRT-III complex are required for the release of infectious hepatitis C virus particles","volume":"91","author":"Corless","year":"2010","journal-title":"J Gen Virol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1709","article-title":"The exosome-associated tetraspanin CD63 contributes to the efficient assembly and infectivity of the hepatitis B virus","volume":"5","author":"Ninomiya","year":"2021","journal-title":"Hepatol Commun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.36233\/0507-4088-173","article-title":"Exosomes in the life cycle of viruses and the pathogenesis of viral infections","volume":"68","author":"Kushch","year":"2023","journal-title":"Problems Virol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1221899110","article-title":"Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells","volume":"110","author":"Ramakrishnaiah","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e1004424","DOI":"10.1371\/journal.ppat.1004424","article-title":"Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with Ago2-miR122-HSP90","volume":"10","author":"Bukong","year":"2014","journal-title":"PloS Pathog"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02225-16","article-title":"Exosome-mediated intercellular communication between hepatitis C virus-infected hepatocytes and hepatic stellate cells","volume":"91","author":"Devhare","year":"2017","journal-title":"J Virol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-021-00425-y","article-title":"Extracellular vesicles and HIV-associated neurocognitive disorders: implications in neuropathogenesis and disease diagnosis","volume":"39","author":"Campbell","year":"2021","journal-title":"Neurotox Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12977-018-0462-x","article-title":"The role of exosomal transport of viral agents in persistent HIV pathogenesis","volume":"15","author":"Patters","year":"2018","journal-title":"Retrovirology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2024.1376455","article-title":"The extracellular vesicles in HIV infection and progression: mechanisms, and theranostic implications","volume":"12","author":"Tang","year":"2024","journal-title":"Front Bioeng Biotechnol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02344-17","article-title":"Nef Secretion into Extracellular Vesicles or Exosomes Is Conserved across Human and Simian Immunodeficiency Viruses","volume":"9","author":"McNamara","year":"2018","journal-title":"mBio"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.662171","article-title":"Exosomes from HIV-1-infected cells stimulate production of pro-inflammatory cytokines through trans-activating response (TAR) RNA","volume":"291","author":"Sampey","year":"2016","journal-title":"J Biol Chem"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2217\/bmm.13.63","article-title":"Exosomes: the future of biomarkers in medicine","volume":"7","author":"Properzi","year":"2013","journal-title":"biomark Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/cgt.2016.77","article-title":"Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer","volume":"24","author":"Nedaeinia","year":"2017","journal-title":"Cancer Gene Ther"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v2i0.20424","article-title":"Comparative marker analysis of extracellular vesicles in different human cancer types","volume":"2","author":"Yoshioka","year":"2013","journal-title":"J Extracell Vesicles"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/657086","article-title":"Exosomes: novel biomarkers for clinical diagnosis","volume":"2015","author":"Lin","year":"2015","journal-title":"ScientificWorldJournal"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.277061","article-title":"Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease","volume":"287","author":"Saman","year":"2012","journal-title":"J Biol Chem"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001874","article-title":"Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury","volume":"70","author":"Zhou","year":"2006","journal-title":"Kidney Int"},{"key":"B52","doi-asserted-by":"publisher","first-page":"7227","DOI":"10.1038\/s41598-018-25515-4","article-title":"Exosome markers associated with immune activation and oxidative stress in HIV patients on antiretroviral therapy","volume":"8","author":"Chettimada","year":"2018","journal-title":"Sci Rep"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000756","article-title":"Elevated abundance, size, and microRNA content of plasma extracellular vesicles in viremic HIV-1+ Patients: correlations with known markers of disease progression","volume":"70","author":"Hubert","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-024-01209-y","article-title":"Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer","volume":"56","author":"Lee","year":"2024","journal-title":"Exp Mol Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3390\/ma15227967","article-title":"Exosome structures supported by machine learning can be used as a promising diagnostic tool","volume":"15","author":"Cansever Mutlu","year":"2022","journal-title":"Materials (Basel)"},{"key":"B56","doi-asserted-by":"publisher","first-page":"RP90390","DOI":"10.7554\/eLife.90390","article-title":"A novel machine learning algorithm selects proteome signature to specifically identify cancer exosomes","volume":"12","author":"Li","year":"2024","journal-title":"Elife"},{"key":"B57","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13045-022-01351-y","article-title":"Liquid biopsy: current technology and clinical applications","volume":"15","author":"Nikanjam","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12040943","article-title":"Potential of Plant Exosome Vesicles from Grapefruit (Citrus \u00d7 paradisi) and Tomato (Solanum lycopersicum) Juices as Functional Ingredients and Targeted Drug Delivery Vehicles","volume":"12","author":"Kilasoniya","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"B59","doi-asserted-by":"publisher","first-page":"5983","DOI":"10.2147\/IJN.S425173","article-title":"Identifying the Potential of miRNAs in Houttuynia cordata-Derived Exosome-Like Nanoparticles Against Respiratory RNA Viruses","volume":"18","author":"Zhu","year":"2023","journal-title":"Int J Nanomedicine"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2023.137963","article-title":"Plant exosome-like nanovesicles derived from sesame leaves as carriers for luteolin delivery: Molecular docking, stability and bioactivity","volume":"438","author":"Jiang","year":"2024","journal-title":"Food Chem"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e2401466","DOI":"10.1002\/adhm.202401466","article-title":"Oral piwi-interacting RNA delivery mediated by green tea-derived exosome-like nanovesicles for the treatment of aortic dissection","volume":"13","author":"Liu","year":"2024","journal-title":"Adv Healthc Mater"},{"key":"B62","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/s12951-024-02663-6","article-title":"Oral administration of Robinia pseudoacacia L. flower exosome-like nanoparticles attenuates gastric and small intestinal mucosal ferroptosis caused by hypoxia through inhibiting HIF-1\u03b1- and HIF-2\u03b1-mediated lipid peroxidation","volume":"22","author":"Wang","year":"2024","journal-title":"J Nanobiotechnology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e14393","DOI":"10.1111\/jfbc.14393","article-title":"Usage of celery root exosome as an immune suppressant; Lipidomic characterization of apium graveolens originated exosomes and its suppressive effect on PMA\/ionomycin mediated CD4+ T lymphocyte activation","volume":"46","author":"Ta\u015fl\u0131","year":"2022","journal-title":"J Food Biochem"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.908830","article-title":"Momordica charantia Exosome-Like Nanoparticles Exert Neuroprotective Effects Against Ischemic Brain Injury via Inhibiting Matrix Metalloproteinase 9 and Activating the AKT\/GSK3\u03b2 Signaling Pathway","volume":"13","author":"Cai","year":"2022","journal-title":"Front Pharmacol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s12010-018-2913-1","article-title":"In vitro wound healing activity of wheat-derived nanovesicles","volume":"188","author":"\u015eahin","year":"2019","journal-title":"Appl Biochem Biotechnol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.fmre.2023.09.007","article-title":"Plant-derived nanovesicles: Promising therapeutics and drug delivery nanoplatforms for brain disorders","volume":"5","author":"Wang","year":"2023","journal-title":"Fundam Res"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12822","article-title":"MicroRNAs and exosomes: key players in HIV pathogenesis","volume":"21","author":"Sadri Nahand","year":"2020","journal-title":"HIV Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3390\/v7072810","article-title":"Exosomes: implications in HIV-1 pathogenesis","volume":"7","author":"Madison","year":"2015","journal-title":"Viruses"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph13010032","article-title":"Micro RNA in exosomes from HIV-infected macrophages","volume":"13","author":"Roth","year":"2015","journal-title":"Int J Environ Res Public Health"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.24875\/AIDSRev.M17000007","article-title":"Exosomes as new players in HIV pathogenesis - new data from the IAS 2017","volume":"19","author":"Poveda","year":"2017","journal-title":"AIDS Rev"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15432","article-title":"Clinical applications for exosomes: Are we there yet","volume":"178","author":"Perocheau","year":"2021","journal-title":"Br J Pharmacol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.811971","article-title":"Review on strategies and technologies for exosome isolation and purification","volume":"9","author":"Chen","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102121","article-title":"A comprehensive review on recent advances in exosome isolation and characterization: Toward clinical applications","volume":"50","author":"Dilsiz","year":"2024","journal-title":"Transl Oncol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"100029","DOI":"10.1016\/j.vesic.2023.100029","article-title":"Guidelines for clinical translation and commercialization of extracellular vesicles and exosomes based therapeutics","volume":"2","author":"Cheng","year":"2023","journal-title":"J Extracell Vesicles"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.14348\/molcells.2022.2033","article-title":"Manufacturing therapeutic exosomes: from bench to industry","volume":"45","author":"Ahn","year":"2022","journal-title":"Mol Cells"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e2165","DOI":"10.1002\/rmv.2165","article-title":"HIV-1 viral load testing in resource-limited settings: Challenges and solutions for specimen integrity","volume":"31","author":"Newman","year":"2021","journal-title":"Rev Med Virol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12357","article-title":"Systemic inflammation and liver damage in HIV\/hepatitis C virus coinfection","volume":"17","author":"Shmagel","year":"2016","journal-title":"HIV Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1282860","article-title":"EV products obtained from iPSC-derived MSCs show batch-to-batch variations in their ability to modulate allogeneic immune responses in vitro","volume":"11","author":"Tertel","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"B79","unstructured":"EMA Scientific recommendations on classification of ATMP"},{"key":"B80","unstructured":"Regulation of human cells, tissues, and cellular and tissue-based products (HCT\/Ps) \u2013 small entity compliance guide\n          \n          \n          \n          2022"},{"key":"B81","doi-asserted-by":"publisher","first-page":"30087","DOI":"10.3402\/jev.v4.30087","article-title":"Applying extracellular vesicles based therapeutics in clinical trials \u2013 an ISEV position paper","volume":"4","author":"Lener","year":"2015","journal-title":"J\u00a0Extracell Vesicles"},{"key":"B82","doi-asserted-by":"publisher","first-page":"101138","DOI":"10.1016\/j.mam.2022.101138","article-title":"The evolving regulatory landscape in regenerative medicine","volume":"91","author":"Beetler","year":"2023","journal-title":"Mol Asp Med"},{"key":"B83","unstructured":""},{"key":"B84","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3390\/ijms21020665","article-title":"Advances in analysis of biodistribution of exosomes by molecular imaging","volume":"21","author":"Yi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae973","article-title":"Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics","volume":"53","author":"Jiang","year":"2025","journal-title":"Nucleic Acids Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1634726\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:17:27Z","timestamp":1763619447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1634726\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":85,"alternative-id":["10.3389\/fimmu.2025.1634726"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1634726","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"article-number":"1634726"}}